Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi F Rothfield

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|January 6, 2006
Systemic lupus erythematosus evolving into rheumatoid arthritisNaomi F Rothfield, Arnold A Lim
Arthritis and Rheumatism|February 12, 2004
Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trialMaureen D Mayes, Daniel O'Donnell, Naomi F Rothfield, et al.
The Clinical Respiratory Journal|July 14, 2012
Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patientsW David Hager, Irina Collins, Janet P Tate, et al.
Arthritis Care & Research|November 12, 2015
ReplyJanet E Pope, Naomi F Rothfield, Rosalind Ramsey-Goldman, et al.
Arthritis Care & Research|March 18, 2015
Treatment Algorithms in Systemic Lupus ErythematosusChayawee Muangchan, Ronald F van Vollenhoven, Sasha R Bernatsky, et al.
The Journal of Rheumatology|February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody contentEng M Tan, Josef S Smolen, J Steven McDougal, et al.
The Journal of Rheumatology|December 17, 2003
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratoriesMarvin J Fritzler, Allan Wiik, Eng M Tan, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
The Journal of Rheumatology|February 15, 2007
Outcome measurements in scleroderma: results from a delphi exerciseHashim Gazi, Janet E Pope, Philip Clements, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|January 6, 2006
Systemic lupus erythematosus evolving into rheumatoid arthritisNaomi F Rothfield, Arnold A Lim
Arthritis and Rheumatism|February 12, 2004
Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trialMaureen D Mayes, Daniel O'Donnell, Naomi F Rothfield, et al.
The Clinical Respiratory Journal|July 14, 2012
Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patientsW David Hager, Irina Collins, Janet P Tate, et al.
Arthritis Care & Research|November 12, 2015
ReplyJanet E Pope, Naomi F Rothfield, Rosalind Ramsey-Goldman, et al.
Arthritis Care & Research|March 18, 2015
Treatment Algorithms in Systemic Lupus ErythematosusChayawee Muangchan, Ronald F van Vollenhoven, Sasha R Bernatsky, et al.
The Journal of Rheumatology|February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody contentEng M Tan, Josef S Smolen, J Steven McDougal, et al.
The Journal of Rheumatology|December 17, 2003
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratoriesMarvin J Fritzler, Allan Wiik, Eng M Tan, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
The Journal of Rheumatology|February 15, 2007
Outcome measurements in scleroderma: results from a delphi exerciseHashim Gazi, Janet E Pope, Philip Clements, et al.
Pageof 2